Health Tools
Hygiene
Naturopathy
Mental health
More Articles
PAP TEST
('Important screening method for pre malignant and malignant conditions of cervix')
Cervical Cancers - the impact:
In women, it is the most common cancer globally,
next only to breast cancer. In India, cervical
cancer is the most common women related
cancer followed by
breast cancer. Every year cervical
cancer is diagnosed in about 5 lakh women globally
and is responsible for more than 2.8 lakh deaths annually. 80% of the cervical
cancers cases are from developing countries like India
The process starts with cervical dysplasia (appearance of abnormal cells in the cervix) and may take more than 10
years to develop into cancer. Moreover cervical
dysplasia causes no symptoms. Several risk
factors are associated with it viz. multiple sexual partners, early onset of sexual activity, smoking, sexually
transmitted diseases like HPV and HIV infection. Hence it is time to consider cervical
cancer screening not as a medical procedure but
as a procedure for providing better quality of life to healthy women.
We at Thyrocare, believe that Prevention is much better than cure. With an aim of providing newer diagnostic services
to the common man at a cost which was never dreamt of, we now offer you preliminary screening test for cervical
cancer the PAP TEST and thus contribute towards
the fight against cancers.
What is a PAP smear
The Papanicolaou test (also called Pap test, Pap smear, cervical smear, smear test) is a preventive medical procedure
designed for healthy, asymptomatic women who might have precancerous or early signs of lesions that could develop
into cervical cancers. This test remains an effective widely used method also for detection of infection or inflammation
in the endocervix and endometrium.
With primary screening done by Pap test, cervical cancer
rates have dropped dramatically in many countries and hence is proven to be most effective in detection of cervical
cancers.
Who should undergo and when
The test is recommended to all women who are sexually active and above the age of 18 years.
The screening interval is usually every year, although, if there have been no previous abnormal tests, the interval may
be extended. If results are abnormal then depending on the nature of abnormality the test is repeated in 3 to 12 months
The testing is carried out when the woman is not menstruating; the best time is between 10 and 20 days after the first
day of the last menstrual period. For about 2 days before a Pap test, she should avoid douching or using vaginal
medicines or spermicidal foams, creams, or jellies (except as directed by a physician). These may wash away or hide
abnormal cells. Also, a woman should not have sexual intercourse for 1 to 2 days before a Pap test, because this may
cause unclear results. Women who have had a total hysterectomy (removal of the uterus and cervix) do not need to undergo
cervical cancer screening, unless the surgery was done
as a treatment for cervical pre-cancer or
cancer.